Lidocaine Hydrochloride Injection, Solution
Product Images NDC 55150-252

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 55150-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))
This product is a sterile, nonpyrogenic solution containing Methylparaben as a preservative. It can be resterilized by autoclaving and should not be used if the solution is discolored or contains a precipitate. It is recommended to store the product at 20° to 25°C (68° to 77°F). The item is manufactured in India for Eugia US LLC in E. Windsor, NJ. The solution is intended for Infiltration and Nerve Block use only and is not suitable for Caudal or Epidural procedures. Each vial contains 100 mg per 10 mL and is a 2% solution (10 mg/mL).*
FDA Label Image

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))

Package Label-principal Display Panel (1% 100 mg per 10 mL (10 mg/mL))
This is a detailed description of Lidocaine NDC 55150-251-24 1 % HCI Injection, USP used for infiltration and nerve block. It contains Lidocaine hydrochloride USP 10 mg per mL with sodium chloride, methylparaben as a preservative, and pH adjusting agents. The product is sterile, nonpyrogenic, and comes in a package of 25 vials of 10 mL each. It is not for caudal or epidural use and can be resterilized by autoclaving if needed. The vial stopper is latex-free, and the product is distributed by Eugia US LLC and is made in India.*
FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))
This text is product information for a pharmaceutical product called Eugie. It is a sterile, nonpyrogenic solution containing Methylparaben as a preservative, and it can be resterilized by autoclaving. The product is indicated for infiltration and nerve block but should not be used for caudal or epidural use. Each vial contains 200mg per 20mL and should be stored at 20° to 25°C. The manufacturer is Eugia US LLC located in E. Windsor, NJ.*
FDA Label Image

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))

Package Label-principal Display Panel (1% 200 mg per 20 mL (10 mg/mL))
This is the essential description of a medical product that contains information about Lidocaine hydrochloride injections. The text mentions details such as the concentration of Lidocaine, other ingredients present in the injection, the recommended dosage, and instructions for use. Additionally, it states that the product is meant for infiltration and nerve block purposes but should not be used for caudal or epidural procedures. It also provides storage instructions, dosage information, and details of the manufacturer, including the fact that it is made in India. Overall, it is useful information for healthcare professionals or individuals using this specific medication.*
FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))
This is a description of Lidocaine HCl Injection, USP containing 200mg per 10mL (20mg/mL). It is indicated for Infiltration and Nerve Block procedures but not for Caudal or Epidural use. The solution includes Methylparaben as a preservative and can be resterilized by autoclaving. The product should not be used if the solution is discolored or contains a precipitate. It is a 10mL Multiple-Dose Vial that is sterile and nonpyrogenic. The storage temperature recommended is 20° to 25°C (68° to 77°F). This product was manufactured in India for Eugia US LLC in E. Windsor, NJ 08520.*
FDA Label Image

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))

Package Label-principal Display Panel (2% 200 mg per 10 mL (20 mg/mL))
This is a medication label for Lidocaine HCI Injection, containing 200 mg per 10 mL. It provides information on dosage, pH adjustment, sterility, storage, and usage instructions like for Infiltration and Nerve Block. The label warns against Caudal or Epidural Use if the solution is discolored or contains a precipitate. It includes details about the preservatives used and the manufacturer.*
FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))
This text appears to be a description of a medical product. It is a sterile, nonpyrogenic solution containing Lidocaine 2% (400 mg per 20 mL) for infiltration and nerve block procedures. The product is recommended for use as specified, not for caudal or epidural administration. Store at 20°to 25°C (68° to 77°F). NDC 55150-255-24. It is advised not to use if the solution is discolored or contains a precipitate.*
FDA Label Image

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))

Package Label-principal Display Panel (2% 400 mg per 20 mL (20 mg/mL))
This is a description of a pharmaceutical product contained in a 25x20 mL multiple-dose vial. The product contains Lidocaine hydrochloride USP and other ingredients, totaling 400 mg per 20 mL. It is sterile, nonpyrogenic, and the vial stopper is not made with natural rubber latex. The product is recommended for infiltration and nerve block procedures and can be resterilized by autoclaving. It should not be used for caudal or epidural purposes, and users are advised not to use if the solution is discolored or contains a precipitate. Methylparaben is used as a preservative, and it should be stored at 20° to 25°C.*
FDA Label Image

Chemical-structure (Lidocaine Str)

Chemical-structure (Lidocaine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.